Effective Growth Strategies for the Soaring Russian Healthcare Market

Research Director Siddharth Saha and Senior Consultant Vitaliy Lehkyy
Attendees will learn about challenges in this diverse marker and pitfalls to avoid; hear about best practices and success stories; and gain insights on effective strategies.

Why Should You Attend:
- Learn best practices and what works and does not from the trenches
- Discover lessons to take from India and China and adopt to Russia
- Assess specific market opportunities for growth
Sep 4 2013
54 mins
Effective Growth Strategies for the Soaring Russian Healthcare Market
More from this community:

Medical Research

Webinars and videos

  • Live and recorded (318)
  • Upcoming (6)
  • Date
  • Rating
  • Views
  • This webinar focuses on new methods and applications in food contamination analysis, bringing together some of the leading experts in food contact materials (FCM) and provides an interactive learning environment for scientists working in this field.

    As food quality and food integrity has become a major topic for the consumer, the penetration path of contaminants in our food chain deriving from the food production and/or the food packaging and storage conditions is gaining attention. Fast and reliable ways of sample preparation and analysis are discussed showing up-to-date examples and how the regulations are applied.
    ______________
    ** Meet the speakers **

    - Sabrina Moret (Associate Professor, Dept. Food Science, University of Udine)

    - Duncan Goodwin (Director of Technical Services, NSF)

    - Susanne Feifel (Product Group Manager for Kjeldahl, Elemental Analysis and Extraction, BÜCHI)
    ______________
    ** What will you gain from this webinar? **

    - You will be provided with tangible ways to streamline your sample preparation to detect mineral oil hydrocarbons in cardboard and food as well as bisphenol A in canned food.

    - BUCHI´s solutions for these applications are presented using examples from industry.

    - Furthermore, you will learn about health and safety risks in the field of food packaging and storage. This will be linked to up-to-date information from the leading regulatory authorities.
  • Alongside established drug target classes, innovative approaches are addressing previously undruggable target classes such as protein–protein interactions. This webinar will provide an overview of how compound profiling using the PLA® (Proximity Ligation Assay) technology can be used for in situ analysis of protein interactions by high content screening as part of the Hit-to-Lead workflow, the key advantage being the ability to provide evidence for target engagement of the compound.

    Proximity ligation is a highly specific and sensitive technology to monitor individual proteins, their interactions and post-translational modifications in situ. It provides single molecule resolution and objective and unbiased quantification in cells and tissues on endogenous expression levels.

    Dr. Bernhard Ellinger (Principal Scientist, European ScreeningPort) will describe how the PLA technology has been optimised for use in an automated 384-well screening format with routines for automated image analysis including spot detection, localisation and quantification. He will present a case study of a small molecule drug discovery project performed in collaboration with a biotech partner. The target mechanism involved the disruption of the interaction between amyloid ß oligomers and RAGE (Receptor for Advanced Glycation Endproducts). Profiling of compounds during Hit-to-Lead stages has involved a variety of high content functional cellular assays including PLA. He will discuss the use of PLA in 384-well format as part of a Hit-to-Lead screening cascade to monitor compound-mediated disruption of this receptor-ligand complex.

    Thomas Juehne (Principal Scientist, Sigma-Aldrich) will discuss Duolink®, which is based on the in situ PLA technology, a highly sensitive and selective way of direct in cell visualisation of endogenously expressed proteins and their interacting partners enabling the use of unmodified primary cells.

    The following trademarks are owned by Olink AB: Duolink® and PLA®
  • SLC transporter-mediated drug–drug interactions (DDI) can significantly impact the pharmacokinetics and safety profiles of drugs. The regulatory agencies (FDA/EMA) recent guidance documents recommend testing six SLC transporters for potential DDI: OATP1B1, OATP1B3, OAT1, OAT3, OCT1 and OCT2. The 2013 drug transporter white paper published by the International Transporter Consortium (ITC) identified additional drug transporters relevant to drug development, including the Multidrug and Toxin Extrusion SLC transporters: MATE1 and MATE2-K. The webinar will introduce a novel cell-based SLC transporter model system - the recently launched “Corning™ TransportoCells™” - for studying regulatory agency recommended SLC transporters. The new system provides a convenient “thaw and go”, high performing mammalian cell model which supports regulatory agency recommendations for evaluating transporter mediated drug-drug interactions in vitro. In this webinar, we will provide an overview of the product validation and applications for the TransportoCells™ transporter model system. Validation data will also be presented for the newly available MATE1 and MATE2-K Corning™ TransportoCells™.
  • Despite our dependence on cultured cells as models, issues surrounding cell identity, choice of appropriate cell lines, conditions of their growth and storage, microbial contamination and over-passaging are often overlooked or misunderstood. Mistakes can have devastating impacts on the legitimacy and reproducibility of science but potentially also, on careers, reputations and funding streams.

    Topics covered:

    Solutions and options for managing cell culture processes
    The Impact of misidentification
    The international consensus on cell identity and qualification
  • Attend this webinar to discover:

    •Changes to healthcare delivery: hospitals of the future, aging in place, cost of care innovations
    •Role of the patient and consumer influence
    •Role of emerging regions as a consumer and competitor
    •Novel industry business models
    •Key disruptive technologies
  • The truth about delivering clinical research in the UK

    • Are you looking to deliver your research in Europe?
    • Need multiple, reliable sites in each country?
    • Do you want to know why you should come to the UK?

    In the past the UK’s reputation for delivering clinical research was questionable. But that’s all changed. Over the last five years the research landscape here has changed dramatically allowing us to make great strides in delivering research for the life-sciences industry. So whether you’re a small CRO, a medium med tech, or a pharma giant - we can help you.

    The NIHR Clinical Research Network is hosting a live webinar which will explode common myths around the UK’s ability to deliver commercial clinical research.. This session will be hosted by Jonathan Sheffield, CEO of the NIHR Clinical Research Network. It will include performance data that will demonstrate why the UK should be your first choice for clinical research. You can find out:

    • How much the UK’s market volume of commercial contract research (supported by the NIHR) has changed
    • What percentage of the UK’s National Health Service (NHS) is actively delivering commercial contract research studies (with support from the NIHR)
    • On average how many days it takes for NHS sites to get regulatory approval for research to take place (with NIHR support)
    • What percentage of commercial contract studies (supported by the NIHR) are delivered to time and target
    • How the NIHR is keeping clinical research in the public eye
    • How the UK is sharpening its competitive edge by achieving more and more key first global patient milestones
  • The Health Service Journal Clinical Research Impact award winner, Sussex Partnership NHS Foundation Trust, has created an inclusive research network which has given the public, patients, carers and staff the opportunity to learn about and get involved with research in their community.

    Find out why Sussex Partnership were determined to make clinical research everyone’s business and how they implemented their new initiatives.

    This session shares best practice and is aimed at NHS Trusts/primary care practices.
  • Three-dimensional (3D) cell culture environments provide structural and biochemical cues for cellular differentiation and functionality. For specialized cell types such as primary cells, a two-dimensional growth substrate may not be sufficient to support complex cellular behaviors such as cell polarity, morphology, signal transduction, and tissue-specific gene expression. This webinar will highlight applications that rely on 3D materials and systems, including Corning ® Matrigel® Matrix (reconstituted basement membrane), Collagen Type I, Corning PuraMatrix™ Peptide Hydrogel, and permeable supports (cell culture inserts). To demonstrate the effectiveness of these environments, the biological and functional properties of a variety of cell types will be discussed.
  • Frost & Sullivan will provide an outlook for healthcare in 2014 with detailed insights on the regulatory challenges, investment trends, innovation temperature and emerging business models in the Asia-Pacific Healthcare market.
  • M22 - Neue Behandlungsansätze mit IPL und ResurFX-
    Dr. med. Gerd Kautz.
    PB-1005026Rev A
  • Channel
  • Channel profile
Up Down
  • The Role of Telecommunications in Healthcare Disruption May 6 2014 2:00 pm UTC 60 mins
    Telecom companies are increasingly seeking new revenue streams by exploring vertical markets like healthcare. While the industry presents promising opportunities, few telecommunication service providers have been able to establish successful business models in this space.

    Frost & Sullivan will present insights on critical factors that companies overlook while developing their healthcare strategies.
  • Healthcare 2020: Disrupt, Transform and Collapse Recorded: Mar 19 2014 57 mins
    Attend this webinar to discover:

    •Changes to healthcare delivery: hospitals of the future, aging in place, cost of care innovations
    •Role of the patient and consumer influence
    •Role of emerging regions as a consumer and competitor
    •Novel industry business models
    •Key disruptive technologies
  • Asia-Pacific Healthcare Outlook 2014 Recorded: Feb 13 2014 44 mins
    Frost & Sullivan will provide an outlook for healthcare in 2014 with detailed insights on the regulatory challenges, investment trends, innovation temperature and emerging business models in the Asia-Pacific Healthcare market.
  • Technology Breakthroughs in Sleep Apnea Recorded: Nov 21 2013 48 mins
    Attend this webinar to discover:

    • Insight into the sleep apneic industry
    • Drivers and restraints of the industry
    • Current trends and technology roadmap
  • Are Biosimilars the Road to Certain Success or a High-Risk Venture? Recorded: Oct 17 2013 45 mins
    Why You Should Attend:

    • Discover the issues involved in regulatory and payer acceptance of biosimilars in the US
    • Learn how biosimilars are forecast to penetrate the various biopharmaceutical segments and therapeutic areas
    • Understand the potential risks and rewards of this market
    • Gain insight into the competitive environment and the potential US market leaders
    • Identify the factors with the potential to impact the uptake of biosimilars
  • 3-D Printing - Healthcare in a Printed World Recorded: Oct 7 2013 34 mins
    With the current advancements in 3-D printing technologies for customized fabrication of complex polymer-based objects, there is much focus on adapting the 3-D printing technologies for healthcare applications. This has aroused interests in engineering bioprinting devices that can develop 3-D structures and at the same time accommodate the incorporation of living cells.

    - The session will discuss the following:
    - The potential of 3-D printing in healthcareD
    - Drivers and challenges for the technology
    - Impact of 3-D printing, scenario melling
  • Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology Recorded: Oct 2 2013 47 mins
    GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
  • New Era in Revenue Cycle Management Emerges as Healthcare Transforms Recorded: Sep 24 2013 58 mins
    Why You Should Attend:

    • Learn what RCM is and why it is so important

    • Discover why healthcare providers are increasing their focus on technology solutions to improve end-to-end RCM

    • Review the major disruptive trends in the industry

    • Find out how next-generation technology solutions will help providers streamline and enhance their RCM process
  • Effective Growth Strategies for the Soaring Russian Healthcare Market Recorded: Sep 4 2013 54 mins
    Attendees will learn about challenges in this diverse marker and pitfalls to avoid; hear about best practices and success stories; and gain insights on effective strategies.

    Why Should You Attend:
    - Learn best practices and what works and does not from the trenches
    - Discover lessons to take from India and China and adopt to Russia
    - Assess specific market opportunities for growth
  • Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology Recorded: Aug 29 2013 49 mins
    GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
  • Outlook of Iran and Azerbaijan Healthcare Markets Recorded: Aug 1 2013 36 mins
    This analyst briefing will discuss:

    - High government focus on growth of the healthcare industry and implementing healthcare reforms
    - Growing economies, with their oil-rich and wealthy position
    - Increasing awareness and affluence among their population for healthcare consumption
  • Original Drugs Pave the Way for Follow-on-Biologics Recorded: Jun 18 2013 29 mins
    With the impending patent expiries of biologic drugs, there is a huge market potential for subsequent entry biologics. A strong integration of R&D and marketing is key to success, and this briefing will highlight the technology advancements.

    Why you should attend:
    ·Learn about the growth of follow-on-biologics
    ·Identify the drivers and restraints
    ·Discuss trends in technology development
  • Will BRIC be the Savior for the Life Sciences and Medical Devices Sector? Recorded: May 15 2013 59 mins
    Attend this webinar to discover:

    ·Insight from BRIC healthcare leaders as they share field experiences and best practices gathered through hundreds of successful cases
    ·Common obstacles international companies must overcome in these regions
    ·How to exploit the hidden potential of BRIC countries
    ·Tactics to adjust strategy to successfully penetrate BRIC markets
    ·The top 10 technologies and products expected to drive growth in these regions
  • Global Trends and Transitions Shaping the Future of Medical Imaging Equipment Recorded: Apr 25 2013 39 mins
    Attend this webinar to discover:

    •Evaluate market potential for basic and advanced medical imaging modalities
    •Learn about important market characteristics and trends
    •Identify opportunities for growth in medical imaging equipment markets within each region of the world
    •Consider factors affecting market growth internationally
  • APAC Market Poised for Electronic Medical Record Growth Recorded: Apr 25 2013 32 mins
    As the healthcare industry across APAC moves toward digitization, electronic health information exchange becomes a stepping stone to success. Governments, non-profit entities and the private sector are aggressively investing in Electronic Medical Record (EMR) and Electronic Health Record (EHR) systems. This Frost & Sullivan briefing presents a comprehensive analysis of the EMR and EHR markets in APAC, with special focus on emerging opportunities in the region.

    Why You Should Attend:
    - Learn about the rapidly developing EMR and EHR markets in APAC
    - Understand key market drivers and restraints
    - Identify leading market participants and their role in the competitive environment
    - Recognize areas of growth within this space
  • Features, Strategies and Promises of Medical Imaging Recorded: Apr 11 2013 24 mins
    Hospital revitalisation initiatives serve as the major driver for improved medical imaging equipment within the public healthcare sector. Growth of the market within the private sector is increasing in proportion to the rapidly emerging technology within the medical imaging space as private healthcare end users try to remain competitive. This briefing will investigate the dynamics of the South African medical imaging market, with specific reference to five key device segments, including, general X-rays, fluoroscopy, mammography, computed tomography (CT) scanners and magnetic resonance imaging (MRI) scanners.
  • 2013 Global Medical Devices Outlook Recorded: Apr 4 2013 52 mins
    This presentation seeks to highlight:
    - Market projections for the global medical devices market
    - Identification of market sectors and sub-sectors poised for expansion
    - Discussion of key market opportunities in emerging markets
    - Strategies for success in the new market paradigm
  • Latin American Electronic Medical Record Market Analysis Recorded: Mar 26 2013 24 mins
    This briefing will investigate how regulations and hospital needs stimulate the EMR market in Latin America and will specially focus on how these regulations will potentially encourage the EMR implementation until 2017.

    Why You Should Attend:
    ·Learn about the market dynamics of EMR in the region
    ·Identify the drivers and restraints impacting the EMR market for the next six years
    ·Discover business opportunities
  • Top Five Growth Sectors in the Asia Pacific Healthcare Market Recorded: Mar 21 2013 56 mins
    Top Five Asia Pacific Growth Sectors:
    •Medical Tourism: Driven by rising affluence and increasing demand for quality healthcare, medical tourism is one of the top growth sectors in APAC in the short to medium term.
    •Outpatient Surgery: This is a lucrative business option that requires less investment, with more profitability.
    •Specialty Hospitals: Due to increasing lifestyle diseases, such as diabetes and coronary heart disease, Asia Pacific is a large marketplace for specialty hospitals.
    •Private Medical Insurance: The increasing cost of healthcare, coupled with low penetration rates of public insurance, creates an expansive market for private insurance companies. Consumer empowerment will also spike private medical insurance revenues.
    •Healthcare IT: To remain competitive by increasing operational efficiency, clinical outcomes and financial profitability, private and public hospitals will invest extensively in installing, maintaining and upgrading IT capabilities.
  • The Globalization of In Vitro Diagnostics Markets Recorded: Mar 14 2013 40 mins
    Why You Should Attend:
    ·Understand the risks and opportunities for IVD competitors across major markets.
    ·Rank the IVD segments by largest opportunity and by fastest growing.
    ·Learn competitive strategies employed by IVD companies in emerging markets.
Frost & Sullivan Analyst Briefing Series
Through Frost & Sullivan's Healthcare Growth Partnership Services program, clients receive a continuous flow of actionable market, technical, and econometric research, along with applications for growth (our TEAM methodology). Our global team of industry experts continuously monitors the following Healthcare market sectors: pharmaceuticals and biotechnology, drug discovery technologies, clinical diagnostics, healthcare IT, medical imaging, and medical devices, and provides local expertise along with a global perspective.
Try a powerful marketing platform for your videos and webinars. Learn more  >

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Effective Growth Strategies for the Soaring Russian Healthcare Market
  • Live at: Sep 4 2013 3:00 pm
  • Presented by: Research Director Siddharth Saha and Senior Consultant Vitaliy Lehkyy
  • From:
Your email has been sent.
or close
You must be logged in to email this